Coronavirus: Netherlands, France, Germany, and Italy join forces to secure a vaccine in the EU

Latest News

Contrary to what those who swear by “local” might think. Scientific and medical research is not like pizza that has to be eaten on-site and hot.

To research, experiment, find vaccines, file patents, produce medicines, and finance all of it, significant resources and the best talents are needed without considering their passport, place of work, where they live, or what language they speak.

We gladly leave the nostalgics of their neighborhood and local dialect to their fate.

That is why we happily welcome the information above. If we respect each other mutually, we combine skills; together, we are stronger.


France, Germany, Italy, and the Netherlands have agreed to form an “alliance” aiming to ensure the production of a potential vaccine against Covid-19 in Europe, the Dutch authorities announced on Wednesday.

The four countries “are jointly exploring various promising initiatives and are in discussions with various pharmaceutical companies,” the Dutch Ministry of Public Health stated in a communiquรฉ.

The objective of this “Inclusive Vaccine Alliance” is to produce vaccines on European soil, where possible, the ministry declared. “Germany, France, Italy, and the Netherlands are convinced that a successful outcome requires a common strategy and investments,” it added.

The alliance also aims to ensure that a sufficient number of vaccine doses are available for the European Union and other low-income countries, particularly in Africa. It “also wishes to agree with pharmaceutical companies that a vaccine must become widely accessible, available, and affordable for the EU,” so that the “most vulnerable” can benefit from it, the Dutch authorities explained.

spot_img
- Sponsorisรฉ -Rรฉcupรฉration de DonnรจeRรฉcupรฉration de DonnรจeRรฉcupรฉration de DonnรจeRรฉcupรฉration de Donnรจe

Must read

Reportages